Loading...
Complete remission of critical neurohistiocytosis by vemurafenib
OBJECTIVE: To describe a patient with life-threatening brainstem neurohistiocytosis who recovered completely upon targeted treatment with the V600E mutation-specific BRAF inhibitor vemurafenib. METHODS: We report clinical, histiologic, genetic, and sequential imaging findings, including fluorodeoxyg...
Saved in:
| Published in: | Neurol Neuroimmunol Neuroinflamm |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Lippincott Williams & Wilkins
2015
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4345630/ https://ncbi.nlm.nih.gov/pubmed/25745636 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000078 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|